Novus Acquisition & Development Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
UNH | UnitedHealth Group | Buy |
16
|
$483.70 | $595.09 | 16.19% | 3 | $445.04B |
ELV | Elevance Health | Buy |
14
|
$528.58 | $567.53 | 14.27% | 1 | $122.85B |
CI | The Cigna Group | Outperform |
12
|
$357.04 | $354.48 | 7.83% | 2 | $101.27B |
CNC | Centene | Outperform |
11
|
$73.06 | $88.33 | 23.19% | 11 | $38.99B |
HUM | Humana | Outperform |
14
|
$302.09 | $426.74 | 19.50% | 1 | $36.40B |
MOH | Molina Healthcare | Outperform |
16
|
$342.10 | $393.38 | 20.14% | 1 | $20.05B |
GTS | Triple-S Management | - |
7
|
$35.98 | $19.00 | -100.00% | 0 | $836.01M |
MRDH | Meridian Holdings | - |
0
|
$0.03 | $0.00 | -100.00% | 0 | $3.81M |
DPAT | Dental Patient Care America | - |
0
|
$0.02 | $0.00 | -100.00% | 0 | $0.43M |
CMP | Advanzeon Solutions | - |
-18
|
$0.00 | $0.00 | 0.00% | 0 | $0.01M |